EASIX as a moderately effective prognostic marker for mortality in severe acute pancreatitis: a retrospective study
-
By
-
Lvyuan Shi
-
Lili Cao
-
Dingyuan Wan
-
Lietao Wang
-
Ping Li
-
Siyuan Chen
-
Zhongwei Zhang
-
Min He
-
July 7, 2026
-
Clinical Scorecard: EASIX as a Moderately Effective Indicator of Mortality Prognosis in Severe Acute Pancreatitis: A Retrospective Analysis
At a Glance
| Category | Detail |
|---|
| Condition | Severe Acute Pancreatitis |
| Key Mechanisms | Endothelial activation and dysfunction contributing to multiple organ failure. |
| Target Population | Patients diagnosed with severe acute pancreatitis (SAP). |
| Care Setting | Critical care medicine in an ICU environment. |
Key Highlights
- EASIX is an independent predictor of mortality in SAP patients.
- Overall mortality rate in the study cohort was 28.82%.
- The predictive model incorporating EASIX achieved an AUC of 0.77.
- Non-survivors had significantly elevated EASIX levels compared to survivors.
- External validation of the predictive model is needed before clinical application.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of SAP requires characteristic abdominal pain and persistent organ failure.
Management
- Management should focus on addressing organ failure and monitoring EASIX levels.
Monitoring & Follow-up
- Regular assessment of EASIX and other prognostic factors is recommended.
Risks
- Increased risk of mortality associated with elevated EASIX levels.
Patient & Prescribing Data
340 patients hospitalized with severe acute pancreatitis.
EASIX may serve as a laboratory-based prognostic indicator for mortality risk.
Clinical Best Practices
- Utilize EASIX in conjunction with other clinical indicators for mortality risk stratification.
- Implement a multivariable predictive model for improved accuracy in prognosis.
Related Resources & Content
